Literature DB >> 25262632

Pore size--a key property for selective toxin removal in blood purification.

Stephan Harm1, Dieter Falkenhagen, Jens Hartmann.   

Abstract

PURPOSE: Extracorporeal blood purification systems based on combined membrane/adsorption technologies are used in acute liver failure to replace detoxification as well as to remove inflammatory mediators in sepsis patients. In addition to coating and chemical modification of the surface, pore size significantly controls the selectivity of adsorption materials.
METHODS: This study addresses the adsorption of albumin bound liver toxins, cytokines, and representative plasma compounds on three adsorbents which differ only in pore size distribution. All three adsorbents are based on hydrophobic poly(styrene-divinylbenzene) copolymer matrices and have mean pore sizes of 15, 30, and 100 nm.
RESULTS: The pores of adsorbents act as molecular sieves and prevent the entry of molecules that are larger than their molecular cut-off. The results of this study reveal that adsorbents based on styrene-divinylbenzene polymers with 15 nm pores are suitable for cytokine removal, and the same adsorbents with 30-40 nm pores are the best choice for the removal of albumin-bound toxins in the case of liver failure. Adsorbents with very large pores lack selectivity which leads to uncontrolled adsorption of all plasma proteins. Therefore, hydrophobic adsorbents with large pores offer inadequate plasma compatibility and do not fulfill the requirements for blood purification.
CONCLUSIONS: Biocompatibility and efficiency of adsorbents used for blood purification can improved by fine tuning of adsorbent surface pore distributions.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25262632     DOI: 10.5301/ijao.5000354

Source DB:  PubMed          Journal:  Int J Artif Organs        ISSN: 0391-3988            Impact factor:   1.595


  14 in total

Review 1.  Rationale of Hemoadsorption during Extracorporeal Membrane Oxygenation Support.

Authors:  L Christian Napp; Stephan Ziegeler; Detlef Kindgen-Milles
Journal:  Blood Purif       Date:  2019-05-16       Impact factor: 2.614

2.  Characterization of Adsorbents for Cytokine Removal from Blood in an In Vitro Model.

Authors:  Stephan Harm; Franz Gabor; Jens Hartmann
Journal:  J Immunol Res       Date:  2015-12-07       Impact factor: 4.818

3.  High performance of a unique mesoporous polystyrene-based adsorbent for blood purification.

Authors:  Jian Chen; Wenyan Han; Jie Chen; Wenhui Zong; Weichao Wang; Yue Wang; Guanghui Cheng; Chunran Li; Lailiang Ou; Yaoting Yu
Journal:  Regen Biomater       Date:  2016-12-24

4.  Removal of stabilizers from human serum albumin by adsorbents and dialysis used in blood purification.

Authors:  Stephan Harm; Claudia Schildböck; Jens Hartmann
Journal:  PLoS One       Date:  2018-01-24       Impact factor: 3.240

5.  Carbon Adsorbents With Dual Porosity for Efficient Removal of Uremic Toxins and Cytokines from Human Plasma.

Authors:  D Pavlenko; D Giasafaki; G Charalambopoulou; E van Geffen; K G F Gerritsen; T Steriotis; D Stamatialis
Journal:  Sci Rep       Date:  2017-11-02       Impact factor: 4.379

6.  Detoxification of bilirubin and bile acids with intermittent coupled plasmafiltration and adsorption in liver failure (HERCOLE study).

Authors:  Gabriele Donati; Andrea Angeletti; Lorenzo Gasperoni; Fabio Piscaglia; Anna Laura Croci Chiocchini; Anna Scrivo; Teresa Natali; Ines Ullo; Chiara Guglielmo; Patrizia Simoni; Rita Mancini; Luigi Bolondi; Gaetano La Manna
Journal:  J Nephrol       Date:  2020-07-24       Impact factor: 3.902

7.  Classification of Uremic Toxins and Their Role in Kidney Failure.

Authors:  Mitchell H Rosner; Thiago Reis; Faeq Husain-Syed; Raymond Vanholder; Colin Hutchison; Peter Stenvinkel; Peter J Blankestijn; Mario Cozzolino; Laurent Juillard; Kianoush Kashani; Manish Kaushik; Hideki Kawanishi; Ziad Massy; Tammy Lisa Sirich; Li Zuo; Claudio Ronco
Journal:  Clin J Am Soc Nephrol       Date:  2021-07-07       Impact factor: 8.237

8.  Hydroxyapatite reinforced inorganic-organic hybrid nanocomposite as high-performance adsorbents for bilirubin removal in vitro and in pig models.

Authors:  Yamin Chai; Zhuang Liu; Yunzheng Du; Lichun Wang; Jinyan Lu; Qian Zhang; Wenyan Han; Tingting Wang; Yameng Yu; Lisha Sun; Lailiang Ou
Journal:  Bioact Mater       Date:  2021-05-24

9.  Low-dose polymyxin: an option for therapy of Gram-negative sepsis.

Authors:  Stephan Harm; Franz Gabor; Jens Hartmann
Journal:  Innate Immun       Date:  2016-03-17       Impact factor: 2.680

10.  Bilirubin detoxification using different phytomaterials: characterization and in vitro studies.

Authors:  Betty Titus Mathew; Shaima Raji; Sawsan Dagher; Ali Hilal-Alnaqbi; Abdel-Hamid Ismail Mourad; Sulaiman Al-Zuhair; Mahmoud Al Ahmad; Khaled Abbas El-Tarabily; Amr Amin
Journal:  Int J Nanomedicine       Date:  2018-05-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.